Remestemcel will definitely be approved, and
Rexlemostrocel will receive accelerated approval in 2025.
Cell Therapy News/Articles, page-18012
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.010(1.05%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| 94.5¢ | 97.5¢ | 94.0¢ | $2.076M | 2.161M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 162826 | 96.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 28820 | 3 |
View Market Depth
| Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |